IP Library Granted Patent US 6,890,728
Granted Patent B2
US 6,890,728 · App. 10/116,729 · Granted May 10, 2005

Methods of isolating blood components using a microcentrifuge and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,890,728
App. No.
10/116,729
Granted
May 10, 2005
Kind
B2
Abstract

Methods and apparatuses for the separation a predetermined cellular component from a bodily fluid or tissue by centrifugation are provided. More specifically, this invention provides a method for the separation and isolation of one or more components, such as stem cells, buffy coat, bone marrow cells, erythrocytes, leukocytes, thrombocytes, serum, fluorescently labeled cells, and magnetically labeled cells, from whole blood, bone marrow, buffy coat, fat tissue, muscle tissue, and nerve tissue by centrifugation, wherein the components are isolated while the centrifuge is rotating.

Claims (25)

1. A method of making an autologous platelet gel containing a transfected gene, said method comprising:

a) providing a centrifuge container for receiving and separating a first autologous anticoagulated blood sample;

b) rotating said centrifuge container;

c) providing a first aliquot of said first anticoagulated whole blood sample from a patient to whom said gel is to be applied to said rotating centrifuge container, whereby said whole blood separates radially into an outermost first fraction containing red blood cells, a second fraction comprising a buffy coat containing white blood cells, a third fraction comprising platelets, and a fourth fraction containing platelet poor plasma;

d) withdrawing said buffy coat fraction from said rotating centrifuge container;

e) transfecting said white blood cells in said isolated buffy coat fraction with a vector/gene combination; and

f) combining said buffy coat fraction containing said transfected white blood cells with autologous thrombin and an autologous blood component.

2. The method of claim 1 , wherein said cells are transfected using an adenovirus.

3. The method of claim 1 , further comprising:

g) placing said combination into a mold having a desired geometric shape;

h) allowing said combination to set into said mold to form said autologous platelet gel having said desired shape;

i) removing said autologous platelet gel from said mold; and

j) inserting said autologous platelet gel into a cavity in a patient.

4. The method of claim 3 , wherein said autologous platelet gel secretes protein into said cavity.

5. The method of claim 3 , wherein said autologous platelet gel is capable of promoting tissue remodeling in the tissue in which said cavity is present.

6. An autologous platelet gel prepared by the method of claim 1 .

7. The method of claim 1 , wherein said anticoagulated blood sample is introduced into said centrifuge container and said buffy coat is withdrawn from said container via a lumen.

8. The method of claim 7 , wherein said lumen is a multiple lumen.

9. The method of claim 1 , wherein said autologous blood component is obtained from said first autologous anticoagulated blood sample.

10. The method of claim 9 , wherein said autologous blood component is said platelet rich plasma fraction.

11. The method of claim 10 , further comprising activating the platelets in said platelet rich plasma fraction.

12. The method of claim 1 , wherein said autologous blood component is obtained from a second autologous anticoagulated blood sample.

13. The method of claim 1 , wherein said cells are transfected using mechanical mixing.

14. The method of claim 1 , wherein said cells are transfected using electroporation.

15. The method of claim 1 , wherein the vector is an adenovirus.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2023
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 065269/0604 →
SECURITY INTEREST Recorded Aug 29, 2016
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 039567/0894 →
RELEASE OF SECURITY INTEREST Recorded Apr 7, 2016
From: COMERICA BANK
To: ARTERIOCYTE MEDICAL SYSTEMS MANUFACTURING OF MASSACHUSETTS INCORPORATED
Reel/Frame 038381/0895 →
RELEASE OF SECURITY INTEREST Recorded Mar 28, 2016
From: ESCALATE CAPITAL PARTNERS SBIC I, L.P.
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.
Reel/Frame 038113/0976 →
SECURITY INTEREST Recorded Nov 5, 2014
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.
To: COMERICA BANK
Reel/Frame 034170/0303 →
SECURITY INTEREST Recorded Mar 27, 2014
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.
To: ESCALATE CAPITAL PARTNERS SBIC I, L.P.
Reel/Frame 032538/0560 →